Refine your search
Showing 1 result
Global Medical Affairs Strategy Leader
Editas Medicine
WA
Pharmaceutical
Editas Medicine is seeking a Senior Director, Medical Affairs to lead medical strategy and execution for our lead in vivo program EDIT-401, a potential one-time therapy for LDL cholesterol. You will shape medical communications and engage with key opinion leaders. The ideal candidate has 10+ years in biopharma Medical Affairs or Scientific Communications, experience with curative therapies, and a track record of aligning cross-functional teams with regulatory and clinical goals.
27 day(s) ago
Global Medical Affairs Strategy Leader
Editas Medicine
WA
Pharmaceutical
Editas Medicine is seeking a Senior Director, Medical Affairs to lead medical strategy and execution for our lead in vivo program EDIT-401, a potential one-time therapy for LDL cholesterol. You will shape medical communications and engage with key opinion leaders. The ideal candidate has 10+ years in biopharma Medical Affairs or Scientific Communications, experience with curative therapies, and a track record of aligning cross-functional teams with regulatory and clinical goals.
27 day(s) ago
Posted 27 day(s) ago
Reference: 3174416925
Editas Medicine is seeking a Senior Director, Medical Affairs to lead medical strategy and execution for our lead in vivo program EDIT-401, a potential one-time therapy for LDL cholesterol. You will shape medical communications and engage with key opinion leaders.
The ideal candidate has 10+ years in biopharma Medical Affairs or Scientific Communications, experience with curative therapies, and a track record of aligning cross-functional teams with regulatory and clinical goals.
Apply Now
Already registered?
Sign in to pre-fill your personal details, attachments and more.
Success!
Your application has been submitted.
Email Shortlisted Jobs
Browse Job Locations
Email Sent Successfully!
Your shortlisted jobs have been sent to the recipient. They will receive the email shortly.
Email Failed!
There was an error sending the email. Please try again later.